Britt H. Bolemon
Expertise in
76
conditions

Dr. Britt H. Bolemon

Oncology | Hematology Oncology
65 International Drive, 
Greenville, SC 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
76
conditions
65 International Drive, 
Greenville, SC 

Overview

Britt Bolemon is an Oncologist and a Hematologist Oncology provider practicing medicine in Greenville, South Carolina.

Dr. Bolemon is highly rated in 76 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Lung Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.

Dr. Bolemon is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 2 clinical trials. Dr. Bolemon is currently accepting new patients.

Specialties

Oncology
Hematology Oncology

Licenses

Internal Medicine in SC

Board Certifications

American Board Of Internal Medicine

Fellowships

Wake Forest University Baptist Medical Center

Hospital Affiliations

Prisma Health Greer Memorial Hospital
Prisma Health Greenville Memorial Hospital
Prisma Health Patewood Hospital
Prisma Health Hillcrest Hospital
Prisma Health Oconee Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Prisma Health Cancer Institute – Eastside
65 International Drive, Greenville, SC 29615
Other Locations
Prisma Health Cancer Institute Multidisciplinary Center – Faris Rd.
890 West Faris Road, Suite 320, Greenville, SC 29605
Prisma Health Cancer Institute – Seneca
131 Lila Doyle Drive, Seneca, SC 29672

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
Enrollment Status: Completed
Publish Date: March 20, 2024
Intervention Type: Drug
Study Drug: INC280
Study Phase: Phase 2
An Multi-Center, Randomized, Open-Label Study to Evaluate the Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC Who Failed Either Abiraterone or Enzalutamide
An Multi-Center, Randomized, Open-Label Study to Evaluate the Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC Who Failed Either Abiraterone or Enzalutamide
Enrollment Status: Completed
Publish Date: February 12, 2024
Intervention Type: Drug
Study Drug: GT0918
Study Phase: Phase 2
View 1 Less Clinical Trial

1 Total Publications

Optimal timing of systemic therapy in resectable colorectal liver metastases.
Optimal timing of systemic therapy in resectable colorectal liver metastases.
Journal: The American surgeon
Published: April 12, 2013
Similar Doctors
Expertise in
40
conditions
Dr. Suzanne R. Fanning
Oncology | Hematology Oncology
Expertise in
40
conditions
Dr. Suzanne R. Fanning
Oncology | Hematology Oncology
Referral required
Before you request

Prisma Health Cancer Institute – Eastside

65 International Drive, 
Greenville, SC 
 (0.1 miles away)
864-987-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Suzanne Fanning is an Oncologist and a Hematologist Oncology provider practicing medicine in Greenville, South Carolina. Dr. Fanning is highly rated in 40 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Fanning is board certified in American Board Of Internal Medicine. Dr. Fanning is currently accepting new patients.

Expertise in
93
conditions
Dr. Steven A. Madden
Hematology Oncology | Hematology | Oncology
Expertise in
93
conditions
Dr. Steven A. Madden
Hematology Oncology | Hematology | Oncology
Referral may be required

Advanced Oncology Newberry

298 Commerce Dr, 
Newberry, SC 
 (56.1 miles away)
803-321-3232
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven Madden is a Hematologist Oncology specialist and a Hematologist practicing medicine in Newberry, South Carolina. Dr. Madden is highly rated in 93 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Madden is currently accepting new patients.

Expertise in
23
conditions
Dr. Carla W. Jorgensen
Oncology | Hematology Oncology
Expertise in
23
conditions
Dr. Carla W. Jorgensen
Oncology | Hematology Oncology
Referral may be required
Before you request

Prisma Health Cancer Institute Multidisciplinary Center – Faris Rd.

890 West Faris Road, Suite 320, 
Greenville, SC 
 (5.5 miles away)
864-455-1200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carla Jorgensen is an Oncologist and a Hematologist Oncology provider practicing medicine in Greenville, South Carolina. Dr. Jorgensen is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Jorgensen is board certified in American Board Of Internal Medicine. Dr. Jorgensen is currently accepting new patients.

Frequently Asked Questions about Dr. Britt H. Bolemon

How do I make an appointment with Dr. Britt H. Bolemon?

You can book an appointment with Dr. Britt H. Bolemon by calling their office at 864-987-7000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Britt H. Bolemon a top-rated expert for Lung Adenocarcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Britt H. Bolemon is classified as an Distinguished expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Britt H. Bolemon specialize in?

While Dr. Britt H. Bolemon is a Oncology, they have specific expertise in Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Britt H. Bolemon participate in research or clinical trials?

Yes. Dr. Britt H. Bolemon has published 1 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Britt H. Bolemon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Britt H. Bolemon accept my insurance?

Dr. Britt H. Bolemon accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 864-987-7000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bolemon's expertise for a condition
ConditionClose
    View All 38 Distinguished Conditions
    View All 38 Advanced Conditions
    View All 107 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile